老年肢端肥大症患者的经蝶手术及其结局:与年轻患者的比较
该研究纳入87例连续接受经鼻经蝶手术(TTS)的肢端肥大症患者,分为老年组(≥65岁,24例)与年轻组(<65岁,63例),比较临床特征、麻醉风险与手术结局。老年组美国麻醉医师协会体质状态3级更常见(75% vs 3%,P=0.00001),但围手术期并发症(17% vs 6%,P=0.142)、内分泌缓解(67% vs 71%,P=0.426)及新发垂体功能缺损(4% vs 3%,P=0.625)两组间无显著差异。作者认为TTS对年轻和老年肢端肥大症患者均可视为安全治疗。
要点
- 老年组美国麻醉医师协会体质状态3级占比75%,显著高于年轻组的3%(P=0.00001)。
- 围手术期并发症老年组17% vs 年轻组6%,差异无统计学意义(P=0.142)。
- 内分泌缓解老年组67% vs 年轻组71%,差异无统计学意义(P=0.426)。
核心结论
- 经鼻经蝶手术对年轻和老年肢端肥大症患者均可视为安全治疗。
- 即使老年肢端肥大症患者,成功切除肿瘤也能显著改善合并症。
研究设计与样本
- 纳入87例连续接受经鼻经蝶手术(TTS)的肢端肥大症患者。
- 按年龄分为老年组(≥65岁,24例,27.6%)与年轻组(<65岁,63例,73.4%),比较临床特征、麻醉风险与手术结局。
主要发现
- 术前内分泌与影像学评估两组间无显著差异。
- 美国麻醉医师协会体质状态3级老年组75% vs 年轻组3%(P=0.00001)。
- 围手术期并发症老年组17% vs 年轻组6%(P=0.142),无显著差异。
- 内分泌缓解老年组67% vs 年轻组71%(P=0.426),无显著差异。
- 术后新发垂体功能缺损老年组4% vs 年轻组3%(P=0.625),无显著差异。
关键数值与推荐
- 老年组24例中16例、年轻组63例中45例术后达到内分泌缓解(67% vs 71%,P=0.426)。
- 约三分之一的老年患者合并高血压或糖尿病,在成功切除肿瘤后减少了用药。
临床怎么用
- 作者认为经鼻经蝶手术可考虑作为年轻和老年肢端肥大症患者的安全治疗。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elderly patients with acromegaly who have comorbidities may increasingly encounter perioperative complications; however, little data are available on the risks and outcomes of surgical treatment in these patients. We aimed to analyze and compare the results of transnasal transsphenoidal surgery (TTS) in elderly and younger patients. METHODS: Eighty-seven consecutive patients with acromegaly who underwent TTS were included. We divided the patients into elderly (≥65 years) and younger (<65 years) groups and compared clinical characteristics, anesthesia risk, and surgical outcomes in these 2 groups. RESULTS: The 87 patients included 24 (27.6%) in the elderly group and 63 (73.4%) in the younger group. Preoperative endocrinologic and radiologic assessments showed no significant differences between the 2 groups. Although a grade 3 American Society of Anesthesiologists Physical Status classification was more common in the elderly group (75% vs. 3%; P = 0.00001) owing to the severity of associated diseases, no significant between-group difference in perioperative complications was seen (17% vs. 6%; P = 0.142). Sixteen elderly patients and 45 younger patients achieved endocrinologic remission following surgery (67% vs. 71%; P = 0.426). The incidence rate of postoperative new pituitary deficit was similar in the elderly and younger groups (4% vs. 3%; P = 0.625). Approximately one-third of the elderly patients with diagnosed hypertension or diabetes mellitus tapered their medication after successful tumor removal. CONCLUSIONS: TTS can be considered a safe treatment for both younger and elderly patients with acromegaly. Successful tumor removal provided a significant improvement in comorbidities even in elderly patients with acromegaly.
引用
- Sasagawa Y, Hayashi Y, Tachibana O, et al. Transsphenoidal Surgery for Elderly Patients with Acromegaly and Its Outcomes: Comparison with Younger Patients. World Neurosurg. 2018. PMID: 29966777. doi:10.1016/j.wneu.2018.06.165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。